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Class I MHC molecules associated with R2-microglobulin (a2m) are peptide-
binding proteins on the surface of nearly all nucleated cells and present antigens
to CTL (1) . HLA class I molecules may also associate with other surface proteins
(2-4) and exert a signal-transducing function in these aggregates .
The genes coding for theMHC molecules are the most polymorphic loci known
in higher vertebrates. It is generally held that the noncovalent association between
the monomorphic light chain 02m is essential for the transport of the class I mole-
cule to the surface and that surface expressed HLA molecules are linked to 02M
(1, 5) .
Here we report that in vitro or in vivo activated, but not resting T lymphocytes,
express a considerable number of surface HLA class I heavy chain molecules not
associated with a2m . The conformational properties of such class I molecules un-
linked to 02m (5, 6) are known to be very different from peptide binding, 02M -
associated heavy chain molecules . It is therefore likely that the loss of the 02m and
the conformational alteration ofthis class I protein upon T cell activation have some
important functional implications .
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Materials and Methods
Monoclonal Antibodies.
￿
The CD25 (clone 3G10) and LA45 antibodies were raised against
HUT102 cells in our laboratory ; the CD3 antibodyOKT3 was purchased from Ortho Phar-
maceuticals, Raritan, NJ.The antibody W6/32 (7) reacts with a monomorphic determinant
of human HLA-A,B,C molecules and was purchased form Sera-lab, Sussex, UK, and the
anti-02m antibody (clone SV393) was from Behring, Marburg, FRG. HC10 was a gift of
H . Ploegh (Netherlands Cancer Institute, Amsterdam) (8) .
Stimulation andFluorescence StainingofLymphocytes.
￿
Mononuclear cells(MNC) from healthy
donors and patients were isolated by Ficoll Hypaque (Pharmacia, Uppsala, Sweden) gradient
centrifugation and either freshly analyzed or cultured for 3 d with 2 mg/ml PHA (Wellcome,
Beckenham, UK) inRPMI 1640medium (Gibco, Paisley, UK) supplemented with l0olo FCS
(Flow Laboratories, Beckenham, UK) or 10% human AB serum (gave no difference), L-
glutamine, and antibiotics . Cells were double stained with antibodies CD3-PE, LA45-FITC,
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and CD25-FITC by standard immunofluorescence techniques. The bindingoffluorochrome-
labeled antibodies was evaluated on a FACS 440 cell sorter (Becton Dickinson, Sunnyvale, CA).
DNA Cloning andSequence Anatysis. mRNA from HUT102 cells were enriched three times
with oligo(dT)-cellulose (Pharmacia). cDNA cloning was performed following the protocol
of Gubler and Hoffmann (9). After linker ligation, the cDNA was ligated in the Eco RI site
of XZAP vector (Stratagene, La Jolla, CA, reference 10). The phage library was screened
with the mAb LA45 according to the manual ofthe Protoblot Kit (Promega-Biotec, Madison,
WI). Positive clones were excised to pBLUESCRIPT SK- plasmid with the helper phage
R408 (both Stratagene). Positive inserts were ligated in the Eco RI site of the Okayama Berg
vector (pcEXV3, reference 11) and transfected into COS7 cells using a method described
by Aruffo and Seed (12). Transfected cells were analyzed by standard protocol for im-
munofluorescence staining. Sequencing was done by dideoxychain termination (13) using
restriction fragment clones, T3 and T7 primers, and the Sequenase Kit (U. S. Biologicals,
Cleveland, OH). Data bank search was done with the FASTN algorithm (14) to compare the
DNA sequence with the EMBL data bank (Version 17.0, released November 1988), and with
the FASTPalgorithm (14) to compare the NBRF (Version 15.0, released May 1988) and SWISS-
PROT (Version 11.0, December 1989) data banks.
Immunoprecipitations and Western Blot Experiments.
￿
Immunoprecipitations were carried out
as described elsewhere (15). Briefly, 2 x 108 cells were labeled with Na125I (New England
Nuclear, Boston, MA) with 20 U lactoperoxidase (Sigma Chemical Co., St. Louis, MO) in
0.003% H202 and then lysed with 0.5% NP40. Cell lysates were incubated five cycles for
2 h with the first antibody and overnight with the second antibody (sixth round). The anti-
bodies LA45, W6/32, and HC10 were linked to protein A-Sepharose (Pharmacia). For Western
Blots, SDS-PAGE (16) separated proteins were electrophoretically blotted to nitrocellulose
(Schleicher & Schuell, Dassel, FRG). Protein bands were either detected with biotinylated
LA45 antibody and extr'avidin alkaline phosphatase (biomakor, Rehovot, Israel), or with
LA45 antibody and the Protoblot kit from Promega-Biotech.
Results
Expression ofLA45 on In Vitro andIn Vivo Activated TLymphocytes.
￿
Freshly isolated
MNC of 18 volunteers weakly expressed LA45 in 5 t 4% as analyzed by gating
for lymphoid cells in flow cytometry (Fig. 1 A). Isolated monocytes (n = 3), granu-
locytes (n = 2), and bone marrow MNC (n = 1) were negative (<2%). T lympho-
cytes from 12 healthy individuals activated with PHA became clearly LA45' within
24 h after stimulation with a maximum expression on days 3-6 in a range of 65
t 19% (day 3). Fig. 1, B and D, show 3-d PHA-activated T cellsof one experiment
with 79% LA45' cells and 93% CD25 + cells, respectively. For in vivo activated cells,
we tested freshly isolated blood lymphocytes from patients with infectious mononucle-
osis and found in two of three cases CD3, CD8, and HLA class II-positive cells
expressing LA45 antigen. One patient showed 84% LA45' T cells (Fig. 1 C), the
other 14% LA45' T cells.
Determination of the Molecular Weight of LA45.
￿
The molecular mass of the LA45
antigen as determined by immunoprecipitation and Western Blot techniques turned
out to be 90/45 kD under nonreducing and 45 kD under reducing conditions (for
immunoprecipitation: Fig. 4, lanes e and i; for Western Blot: Fig. 5, lane c). The
slight signal of about 38 kD (Fig. 4, lanes e and i) is co-precipitated by LA45 anti-
body in some experiments.
CloningandSequenceAnalysis ofLA45.
￿
To clone the gene encoding LA45 we created
a cDNA library of the target cell line HUT102 in the prokaryotic expression vector
AZAP By plaque screening with the mAb LA45 we got seven positive clones. We
then subcloned these cDNA clones in the eukaryotic expression vector pcEXV3,d
U
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FIGURE 1.
￿
Fluorescence staining of human T lymphocytes. (A) Normal resting CD3* cells
stained with LA45; (B and D) PHA-activated CD3' cells stained with LA45 (B)andCD25 (D);
and in vivo activated, CD3' cells from a patient with infectious mononucleosis stained with
LA45 (C).
and expressed the recombinant protein in COS7 monkey cells. The expression of
the rLA45 protein was detected in a high amount in the cytoplasm of the COS7
cells, but was only slightly expressed on the cell surface. However, we could demon-
strate, both with metabolically ["S]methionine and surface 1251-labeled cells, that
the transfection-induced recombinant protein has the same size as that expressed
by the target cell line HUT102. An immunoprecipitation ofrecombinant LA45 from
1251-labeled transfected COS cells is shown in Fig. 2.
We then sequenced the gene and found a nucleotide sequence of 1418 bases in-
cluding an open reading frame coding for a protein of 367 amino acids (Fig. 3 A).
A putative deletion, indicated as #, is assumed at position 54 to 55 in the nucleotide
sequence, leading to a shift in the reading frame in the peptide encoded 5' to this
deletion. This part of the protein is coding for a highly hydrophobic leader peptide
as is known for membrane transported proteins.
The comparison of the nucleotide and protein sequence of LA45 with data banks
revealed that LA45 is quite homologous to genes of the HLA class I gene family.
In particular, there is a homology of 92% to the cDNA sequence of HLA-A2 se-
quence over arange of 1306 nucleotides. At the protein level, LA45 is 95% homolo-
gous to the protein sequence of the HLA-Aw68 over a range of 275 amino acids
and of93% homologous to the protein sequence of HLA-A3 over 367 amino acids.
The highly conserved five cysteine residues within the HLA class I genes as well1434
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FIGURE 2 .
￿
Immunoprecipitations of "'I-labeled COS7 cells (12%
SDS-PAGE) . (lane a) LA45-transfectedCOS7 cells, (lane b) untrans-
fected COS7 cells, (lane c)HUT102 cells . From all cell types precipi-
tations were done with LA45 antibody. Molecular masses shown in
kilodaltons.
as the N-glycosylation site (gln-85) ofHLA class I proteins were found . The hydrophi-
licity analysis revealed the typical transmembrane region (aa 303-331) . Therefore,
we separate the protein sequence according to class I proteins in the domains al,
a2, and 0, transmembrane, and cytoplasmic tail . The direct comparison ofLA45
to humanHLA class I proteins is seen in Fig . 3 B . It is noteworthy that LA45 and
HLA-A3 differ only in 23 amino acids .
Comparison ofLA45 with HLA Class I Proteins.
￿
The high homology of LA45 to
HLA class I genes on the one hand and the clearly discrepant cellular expression
pattern on the other hand led us to compare HLA class I proteins and the LA45
in a direct manner. Therefore, we performed sequential immunoprecipitation studies
with the antibody LA45 and the antibody W6/32, reactive with a monomorphic
determinant ofHLA-A,B,C molecules . Clearing a lysate ofHUT102 cells with LA45
antibody revealed that HLA class I and 02m proteins remained (Fig . 4, lanes e-h) .
On the other hand, clearing with W6/32 left behind LA45-reactive structures (Fig .
4, lanes a-d) . The antibody W6/32 precipitated bands at 90 kD and 45 kD under
nonreducing conditions and a band of 45 kD under reducing conditions plus 02m,
a protein of 12 kD (lanes a and k) . However, the LA45 antibody reacts with proteins
of 90 and 45 kD (nonreduced) and 45 kD (reduced) and does not co-precipitate
02m (lanes e and i) .
In view of these data onemay argue that a possible weak association between LA45
and 02m was not detected in immunoprecipitation experiments . However, we couldSCHNABL ET AL.
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also demonstrate that antibody-induced capping of LA45 did not induce capping
ofW6/32 or anti-02m reactive structures, nor did W6/32 or anti-02m-induced cap-
ping lead to cap formation of LA45.
ReactivityofLA45 in Western Blots.
￿
To check ifLA45 antibody reacts withconfor-
mationally altered class I heavy chains, we tested a denatured total cell lysate from
lymphocytes, which rarely express LA45, and found a clear signal with LA45 anti-
body in the Western Blot (Fig. 5, lane b) at 45 kD. The same signal is found with
cell lysatesofHUT102cells, but LA45 antibody was negative in a Western Blotwith
the cell line K562, which is known to be HLA class 1-negative. Furthermore, we
isolated conventional HLA-A,B,C molecules from resting, LA45- T cells with
W6/32 antibody, denatured themwithSDS, and analyzed the PAGE-separated bands
with LA45 antibody. As seen from Fig. 5 (lane a), such denatured material reacts
with LA45 antibody at 45 kD.
Sequential Immunoprecipitation withHCI0.
￿
The reactivity ofLA45 withdenatured
HLA class I heavy chains was further supported by a sequential immunoprecipita-
tion with the antibody HC10 raised against and reactive with SDS denatured, free
class I heavy chain molecule (8). Clearing oflysates from "'iodinated HUT102 cells
with HC10 removed all LA45 reactive material (Fig. 6 A). As a control for this ex-
periment, we included a sequential immunoprecipitation with HC10 and W6/32.
It can be seen from Fig. 6 B that HC10 does not precipitate HLA class I proteins
associated to 02m and recognized by W6/32 antibody. Our results thus strongly sug-
gest that activated T cells and possibly other cells express HLA-A,B,C molecules
not associated with 02M-
Discussion
In our attempt to define newactivation-induced cellular interaction molecules on
human T cells, we raised a mAb (LA45) against the HTLU1 transformed human
Tcell line HUT102. The LA45 antigen is foundon activatedhuman T lymphocytes
with amolecularmass of90/45 kD (nonreduced) and45 kD (reduced) (Fig. 4, lanes
e and i; Fig. 5, lane c).
Molecularcloningand sequence analysis revealedahighhomology ofLA45cDNA
and protein sequence to human HLA class I genes. When comparing the LA45 se-
quence with the grouped HLA class I DNA and protein sequences by Parham et
al. (17, 18) we detected allcharacteristicsofA-ness inourcDNA sequence. We found
the 62 A-locus characteristic nucleotides as well as the two A-specific methionines
(met-138 and met-189) (Fig. 3).
However, HLA class I proteins are known to be expressed on all nucleated cells,
but for LA45 antigens we repeatedly showed that they are virtuallyabsent from the
surface and cytoplasm ofresting peripheral blood and bone marrow mononuclear
and polymorphonuclear cells. After stimulation with PHA we can induce the ex-
pression ofLA45 antigen on Tcells within 24 h. The kinetics ofthe expression of
LA45 antigen on T lymphocytes is rather heterogenous when compared with the
classical activation antigenCD25. However, as shownbyimmunolluorescence (Fig.
1, Band D), thenumberofthese newlyexpressed structures is essentiallycomparable
to thenumberoflow affinity IL-2receptorson activated Tcells(25,000-60,000binding
sites, reference 19).1436 MHC CLASS I HEAVY CHAINS NOT ASSOCIATED WITH 02m
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341 G G S Y S Q A A S S D S A Q G S D M S L T A C R V
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1328 GGCTGAGGTGTCTCCATCTCTGCCTCAAOTTCATGGTGCACTGACCTGTAACTTTTTCCTTCCCTATTAAAATTAGAACCTGACATATTCC
FIGURE 3.
￿
Sequence ofLA45 andcomparison with classI- andclassI-likeproteins. (A)Nucleo-
tide sequence of LA45 cDNA insert and the deduced amino acid sequence (written in single
letter code). Aputative deletion on position 54 or 55 is marked with an asterisk. (#) Aminoacids
alanine, asparagine, glycine, or valine. The glycosylation site is indicated by -CHO-. Cysteine
residues are depicted (SH). (B) Comparison of LA45 protein sequence with human HLA class
I and HLA class I like proteins; a dash indicates identity to LA45. Aw68, A3, A2, B27 are the
amino acid sequencesofHLA-Aw68, HLA-A3, HLA-A2,andHLA-B27derived from theSWISS-
PROT data bank (code: HAIHEHUM, HAIC$HUM, HAIASHUM;HAIP;HUM). HLA-E,
JWT15 and RS5 are the non-HLA-A, B, C protein sequences published in references 21, 22
and 23, respectively. These sequence data have been submitted to the EMBC/GenBank Data
Libraries and have been assigned accession number X51745.
Besides the discrepancy in the serological reaction pattern between HLA class I
proteins and LA45, the two proteins also differ in the association to the 02m. HLA
class I proteins are known to be associated with 02m, a protein of 12 kD. This pro-
tein band was never found to be co-precipitated with LA45 (Fig. 4, lanes e and t).
Therefore, we raised thequestion whetherthe LA45 protein represents an unusual,
non-02m-associated member of the MHC class I family with a cellular distribu-
tion pattern (Fig. 1) clearly different from conventional HLA class I proteins, or
whether our LA45 antibody is simply unusual and detects a hidden epitope of an
otherwise classical HLA-A,B,C molecule that only becomes surface-exposed uponB
signal peptide
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￿
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activation. A sequential immunoprecipitation revealed that W6/32 and LA45 anti-
body and antigen do not crossreact with each other. Furthermore, we could show
that cap formation induced byW6/32 or anti-02m antibodies didnot cap LA45 mol-
ecules and LA45 antibody did not induce capping of HLA class I molecules. This
might suggest that LA45 is a non-02m-associated HLA class I a chain and struc-
turally different from conventional HLA-A,B,C molecules recognized by W6/32 and
anti-02m. These experiments stress the nonassociation of 02m to LA45 and argue
against a possible weak association as it is described for some mouse class I anti-
gens (20). From all these data LA45 could not be termed a classical HLA class I1438
￿
MHC CLASS I HEAVY CHAINS NOT ASSOCIATED WITH 02m
FIGURE 4 .
￿
Sequential immunoprecipitations of
"II-labeled HUT102 cells (16% SDS-PAGE) .
The cell lysate was divided into two portions . In
the first experiment the cell lysate was cleared with
W6/32 (lane a shows the first round, lane b the
second, and lane c the fifth round ofclearing with
W6/32), and afterwards LA45 was precipitated
(lane d). Preclearing of thesame cell lysate with
LA45 antibody was done in the second experi-
ment (lane e: first cycle, lanef . second cycle, and
lane g : fifth cycle precipitation with anti LA45),
and then the lysate wasincubated with W6/32,
as shown in lane h . Lanes a-h : precipitated pro-
teins under nonreducing conditions . Lane i shows
the reducedLA45 precipitate fromthe first round
of the second experiment. Molecular masses
shown in kilodaltons .
antigen . Therefore, we assume the expression of structurally altered HLA class I
proteins on T lymphocytes upon activation .
In the mouse system the Qa/TL antigens represent a group of so called class I
like proteins . Thehuman equivalent oftheseQa/TL proteins has notyetbeen found.
Some non-HLA-A,B,C class I genes have been cloned (21-23) . The cellular expres-
FIGURE 5 .
￿
Reactivity of LA45 antibody in aWestern Blot (12
SDS-PAGE) . (Lane a) W6/32 precipitated proteins were detected
with biotinylated LA45 antibody and extravidin alkaline phos-
phatase ; (lane b) lysate of resting lymphocytes, (lane c) lysate of
HUT102 cells ; (lane d) lysate ofthe cell line K562 . Lysates in lanes
b, c, and d were analyzed with LA45 antibody and the Protoblot
kit from Promega-Biotech.SCHNABL ET AL.
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FIGURE 6 . (A) Sequential immunoprecipita-
tions of 1251-labeled HUT102 cells (12% SDS-
PAGE) . The cell lysate of 1251-labeled HUT102
cells was treated for five cycles of2 h with HC10
immunoadsorbents (lanea and b : first and fifth
round). Lane cshowstheprecipitate ofLA45 from
the same lysate in the sixth round . (B) Sequen-
tial immunoprecipitations of 1251-labeled HUT102
cells (12% SDS-PAGE) . Preclearing ofthe cell ly-
sate with HC10 antibody (lanes aand b : firstand
fifth round). Lane c shows the precipitate of
W6/32 antibody from the same lysate in the sixth
round . Molecular masses shown in kilodaltons .
sion pattern of these class I-like clones, as determined by Northern Blotting is, con-
cerningT lymphocytes, similar to that of LA45 . When aligning the published se-
quences, LA45 is only -75-76% homologous to these genes, compared with a
homology of93% toHLA-A3 (Fig. 3 B) . Alloantisera have been described that seem
to react with non-HLA-A,B,C class I molecules expressed by activated but not resting
lymphocytes (24-27) . All so far reported proteins differ from LA45 as they are 02m
associated and have a slightly lower molecular mass than simultaneously studied
classical HLA-A,B,C antigens . In contrast, LA45 is not associated to 02m and has
an identical molecular mass to the a chain precipitated by W6/32 .
The noncovalent association of the a chain to the 02m is mainly generated by
some amino acids in the a3-subunit of the heavy chain in a very short distance to
the 02m in the formed complex (28) . We checked the protein sequence of LA45 for
mutations in these amino acids and could notdetect any different amino acid com-
pared with the HLA-A2 protein sequence . Therefore, the lack of the 02m associa-
tion ofLA45 cannot be explained by a mutation in the amino acids responsible for
the protein aggregation .
The association of the heavy chain and the 02m occurs posttranslationally in the
cytoplasm and is accompanied by a conformational change of the heavy chain (1,
5) . This alteration can be reversed by in vitro denaturation ofHLAclass I aggregates .
Most of the antibodies against a heavy chain-02m complex do not react with the
free heavy chains . Furthermore, it was stressed that the association of02m to the
heavy chain is essential for the membrane transport of functional class I proteins .
In contrast, Allen et al . (29) demonstrated that the transfected murine class I mole-
cule H-2D6 can be surface expressed in the absence of02m. These free heavy chains
display a significantly altered conformation unrecognized by allospecific and Db-1440
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restricted CTL or by most alloantibodies. These findings raised the idea, that our
LA45 is a structurally altered class I protein, expressed without 02m, and there-
fore is not recognized by W6/32. To delineate this issue, we performed a Western
Blot with purified HLA class I proteins denatured in vitro by SDS-PAGE. Wecould
detect these antigens with the antibody LA45 on the nitrocellulose. Therefore, denatu-
ration ofconventional W6/32-reactive HLA-A,B,C molecules and dissociation from
02m thus seems to alter a chains in such a way that they become reactive with our
LA45 antibody (Fig. 5, lane a).
This conclusion is further supportedby a sequential immunoprecipitationin which
we showed that the LA45 antibody and an antibody HC10, reacting with in vitro
denatured class I heavy chains, recognize the same proteins on HUT102 cells (Fig.
6 A, lanes a-c). These molecules are structurally different from conventional, 02m-
linked MHC class I proteins and can only be detected with antibodies recognizing
the free heavy chain such as LA45 antibody, but not with antibodies reacting with
the intact heavy chain-02M complex such as the classical HLA-A,B,C-reactive an-
tibody, W6/32.
This all confirms the previous speculationthat activatedTcells express structur-
ally altered, non-02m-associated heavy chains. Whether these structures represent
a separatealloantigensystem remainstobeseen. However, mitogen-stimulated MNC
of 12 normal donors showed LA45 reactivity, although they had mismatching HLA
phenotypes with HUT102 cells. Furthermore, in an isoelectrofocusing experiment
the LA45 precipitates showed the same reaction pattern when compared with the
W6/32 precipitates, although the bands precipitated by LA45 antibody showed a
different intensity to W6/32 precipitates, and a certain preference for HLA-A locus
proteins were detected (data not shown). This leads us to the conclusion that on
activated T cells and possibly other cells, products of all HLA class I gene loci can
be found in association with 02m as well as in a free, conformationally altered form.
Additionally, the LA45 antibody defines amonomorphic determinant on free HLA
class I heavy chains.
So far, we have not tested ifthese "free" heavy chains with altered conformation
get surface expressed without a biosynthetical association with 02m. Another pos-
sibility, which we in fact favor, would be a functional exchange ofa02m with athird-
party molecule. One candidate for such an associated molecule would certainly be
the 38 kD protein observed by us, which was co-precipitated by LA45 antibody in
three of five experiments. The trivial possibility that an exchange of human 02m
with constituents and in particular bovine /02m (30) might be possible, for the in
vitro changes could be ruledout. Identical results were obtainedwith culture media
supplemented with human serum.
Our working hypothesis for these findings is that activation ofT lymphocytes is
accompanied by loss of association of02m with the known heavy chain HLA class
I molecules. A likely explanation for the lack ofheavy chain-02M association is that
the heavy chain is associated with a new structure, thereby displacing I02m. It seems
probable that this change has functional importance given the presence ofnon-02M-
associated heavychains on activated cellsbut apparently not on precursor cells. The
possible nature ofnew molecules with which the "free" heavy chains can associate
and the potential functional importance of such associations are important issues
arising from these studies.SCHNABL ET AL.
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Summary
We present here the molecular characterization of a new activation-induced sur-
face structure on human T lymphocytes, termed LA45, with high homology (93%
at protein level) to MHC class I molecules. Antigen modulation and sequential im-
munoprecipitation experiments revealed that LA45 and HLA class I proteins do
not crossreact with the corresponding antibodies. Furthermore, LA45 is not associated
with R2-m. On the other hand, we could show that the separation of HLA-A,B,C
and 02m molecules, induced by SDS-denaturation, leads to a conformational
change in the heavy chain in such a way that it becomes reactive with LA45. The
90/45 kD LA45 proteins thus appear to be non-02m-associated MHC class I a
chains that are selectively expressed by activated but not by resting human T lym-
phocytes .
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